Contracts › 75N95022F00002
75N95022F00002: Analytical Method Development, Validation and Stability Study of Orc-13661
Awarded to Mriglobal by National Institutes of Health (NIH).
$482Kobligated
$616Kpotential value
30 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95022F00002 |
|---|---|
| Vehicle | HHSN271201700006I |
| Awardee | Mriglobal |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325411 Medicinal and Botanical Manufacturing |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MO |
| Offers received | 2 |
| Period of performance | 29 September 2022 to 30 June 2027 |
| Potential end | 30 June 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325411 contracts · All expiring contracts · USASpending record